Cervix carcinomas: Place of intensity-modulated radiotherapy;Les cancers du col utérin : place de la radiothérapie avec modulation d'intensité

Cancer/Radiotherapie

Volumn 13, Issue 6-7, 2009, Pages 507-510

  Barillot, I ^a,b  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Cervix carcinomas; Complications; Dose escalation; Intensity modulated; Radiation therapy

Indexed keywords

COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RECTUM; SHORT SURVEY; UTERINE CERVIX CARCINOMA; ARTICLE; BLADDER; CANCER STAGING; MALE; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; RADIOGRAPHY; UTERINE CERVIX TUMOR; VAGINA;

FEMALE; HUMANS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 70350708401     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.05.015     Document Type: Short Survey

References (35)

1. Ahamad A.A., D'Souza W.D., Salehpour M., Salehpour M.R., Jhingran A., and Eifel P.J. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal tissue sparing effect to margin size. Int J Radiat Oncol Biol Phys 62 (2005) 1117-1124
2. Ahmed R.S., Kim R.Y., Duan J., Meleth S., De Los Santos J.F., and Fiveash J.B. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 60 (2004) 505-512
3. Aygodan B., Mundt A.J., Smith B.D., Mell L.K., Wang S., Sutton H., et al. A dosimetric analysis of intensity modulated radiation therapy (IMRT) as an alternative to adjuvant high dose rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiation Oncology Biol Phys 65 (2006) 266-273
4. Beriwal S., Gan G.M., Heron D.E., Selvaraj R.N., Kim H., Lalonde R., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68 (2007) 166-171
5. Chen M.F., Tseng C.J., Tseng C.C., Kuo Y.C., Yu C.Y., and Chen W.C. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1438-1444
6. Das I.J., Lanciano R.M., Movsas B., Kagawa K., and Barnes S.J. Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. Int J Radiat Oncol Biol Phys 39 (1997) 67-76
7. D'Souza W.D., Ahamad A.A., Iyer R.B., Salehpour M.R., Jhingran A., and Eifel P.J. Feasability of dose escalation using intensity modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1062-1070
8. Duan J., Kim R.Y., Elassal S., Lin H.Y., and Shen S. Conventional high dose rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage. Int J Radiat Oncol Biol Phys 71 (2008) 765-771
9. Esthappan J., Mutic S., Malyapa R.S., Grigsby P.W., Zoberi I., Dehdashti F., et al. Treatment planning guidelines regarding the use of CT-PET guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 58 (2004) 1289-1297
10. Gerstner N., Wachter S., Knocke T.H., Fellner C., Wambersie A., and Pötter R. The benefit of beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol. 51 (1999) 71-78
11. Green N., Iba G., and Smith W.R. Measures to minimize small intestine injury in the irradiated pelvis. Cancer 35 (1975) 1633-1640
12. Herbert S.H., Solin L.J., Hoffman J.P., Schultz D.J., Curran Jr. W.J., Lanciano R.M., et al. Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander. Int J Radiat Oncol Biol Phys 25 (1993) 885-893
13. Heron D.E., Gerszten K., Selvaraj R.N., King G.C., Sonnik D., Gallion H., et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. Gynecol Oncol 91 (2003) 39-45
14. Hong L., Alektiar K., Chui C., LoSasso T., Hunt M., Spirou S., et al. IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys 54 (2002) 278-289
15. Kavanagh B.D., Gieschen H.L., Schmidt-Ullrich R.K., Arthur D., Zwicker R., Kaufman N., et al. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 38 (1997) 561-568
16. Kavanagh B.D., Schefter T.E., Wu K., Tong S., Newman F., Arnfield M., et al. Clinical application of intensity modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 12 (2002) 260-271
17. Kavanagh B.D., Segreti E.M., Koo D.T., Amir C., Arthur D., Wheelock J., et al. Long-term local control and survival after concomitant boost accelerated radiotherapy for locally advanced cervix cancer. Am J Clin Oncol 24 (2001) 113-119
18. Lujan A.E., Mundt A.J., Yamada S.D., Tong S., Newman F., Arnfield M., et al. Intensity modulated radiotherapy as a means of reducing dose to bone marrow in gynaecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 516-521
19. Maingon P., Bolla M., Truc G., Bosset M., Peignaux K., Ammor A., et al. La radiothérapie de conformation avec et sans modulation d'intensité dans le traitement du cancer localisé de la prostate. Cancer Radiother 9 (2005) 382-387
20. Mell L.K., Tiryaki H., Ahn K.H., Mundt A.J., Roeske J.C., and Aydogan B. Dosimetric comparison of bone marrow sparing intensity modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 1504-1510
21. Mundt A.J., Lujan A.E., Rotmensch J., Waggoner S.E., Yamada S.D., Fleming G., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52 (2002) 1330-1337
22. Mundt A.J., Mell L.K., and Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56 (2003) 1354-1360
23. Mundt A.J., Roeske J.C., Lujan A.E., Yamada S.D., Waggoner S.E., Fleming G., et al. Initial clinical experience with intensity-modulated whole-pelvic therapy in women with gynecologic malignancies. Gynecol Oncol 82 (2001) 456-463
24. Mutic S., Malyapa R.S., Grigsby P.W., Dehdashti F., Miller T.R., Zoberi I., et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes - a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55 (2003) 28-35
25. Peters W.A., Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
26. Portelance L., Chao C., Grigsby P.W., Bennet H., and Low D. Intensity modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 261-266
27. Roeske J.C., Lujan A., Reba R.C., Penney B.C., and Diane Yamada S. Incorporation of SPECT bone marrow imaging into intensity modulated whole pelvic radiation therapy treatment planning for gynecologic malignancies. Radiother Oncol. 77 (2005) 11-17
28. Roeske J.C., Lujan A., Rotmensch J., Waggoner S.E., Yamada D., and Mundt A.J. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
29. Salama J.K., Mundt A.J., Roeske J., and Mehta N. Preliminary outcome and toxicity report of extended field intensity modulated radiation therapy for gynaecologic malignancies. Int J Radiat Oncol Biol Phys 65 (2006) 1170-1176
30. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I., and Zaino R.J. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage 1B carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Gynecol Oncol 73 (1999) 177-183
31. Shanahan T.G., Mehta M.P., Bertelrud K.L., Buchler D.A., Frank L.E., Gehring M.A., et al. Minimization of small bowel volume within treatment fields utilizing customized "Belly Boards". Int J Radiat Oncol Biol Phys 19 (1990) 469-476
32. Société française de radiothérapie oncologique. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 2008;12:143-313.
33. Tao Y., Lefkopoulos D., Ibrahima D., Bridier A., Polizzi Mdel P., Wibault P., et al. Comparison of dose contribution to normal pelvic tissues among conventional, conformal, and intensity modulated radiotherapy techniques in prostate cancer. Acta Oncol 47 (2008) 442-450
34. Van Kasteren Y.M., Burger C.W., Meijer O.W., Helmerhorst T.J., and Kenemans P. Efficacy of a synthetic mesh sling in keeping the small bowel in the upper abdomen to prevent radiation enteropathy in gynecologic malignancies. Eur J Obstet Gynecol Reprod Biol 50 (1993) 211-218
35. Wong E., D'Souza D.P., Chen J.Z., Lock M., Rodrigues G., Coad T., et al. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies. Int J Radiat Oncol Biol Phys 61 (2005) 830-841